Olanzapine

HCID 135398745

Notizen Reaktionen

Teilstruktursuche Ähnliche Strukturen suchen

Grundinformationen

CAS: 132539-06-1
Standard-SMILES: Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
InChIKey: KVWDHTXUZHCGIO-UHFFFAOYSA-N
Summenformel: C17H20N4S
Durchschnittliche Molmasse: 312,4 g/mol
Monoisotopische Masse: 312,14086783

Namen und Bezeichner

Bevorzugter Name: Olanzapine
IUPAC: 2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine
Englischer Name: Olanzapine
Summenformel: C17H20N4S
Molmasse: 312.43

Namen und Synonyme

olanzapine132539-06-1OlansekZyprexa ZydisZalastaZyprexa VelotabZyprexa IntramuscularolanzapinaOlanzapine MylanLY-1700532-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine

Weitere Namen anzeigen

ZYPREXAOLANZAPINE FORM IIOLANZAPINE FORM I2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine, LY-170053, ZyprexaLarmacOleanzOlanzneIntegrolOlanzapine (200 mg)4-Amino-2-methyl-10H-Thineo(2,3b)(1,5)benzodiazepine HCL

OlazaxOlanzapine TevaOlazax DisperziOlanzapine GlenmarkolanzapinumLY 170053Olanzapine ciplaOlanzapine apotex

Datenbank-Bezeichner

CAS: 132539-06-1
PubChem CID: 135398745
DTXSID: DTXSID9023388
ChEMBL: CHEMBL715
ChEBI: CHEBI:7735
UNII: N7U69T4SZR
EC Number: 603-618-4
Nikkaji: J489.991A

Eigenschaften

Berechnete Struktureigenschaften

XLogP: 2,9
Polarare Oberfläche (TPSA): 59,1 Å²
H-Brücken-Donoren: 1
H-Brücken-Akzeptoren: 4
Frei drehbare Bindungen: 1
Schwere Atome: 22
Formalladung: 0
Komplexität: 432

Physikochemische Eigenschaften

Schmelzpunkt: 195 °C · 195°C
Siedepunkt: 476 · 476.0±55.0 °C(Predicted)
Dichte: 1.32 · 1.32±0.1 g/cm3(Predicted)
Flammpunkt: 2 ℃ · 2℃
storage temp.: 2 · 2-8°C
Löslichkeit: 15 mg/mL · DMSO: >15mg/mL
pka: 7.78 · 7.78±0.20(Predicted)
Aggregatzustand: powder
Farbe: yellow
Merck: 14 · 14,6822
BRN: 7655141 · 7655141
Henry's Law Constant: 1.3 · 1.3×109 mol/(m3Pa) at 25℃, HSDB (2015)
BCS Class: 2 · 2
Major Application: pharmaceutical (small molecule)
InChI: InChI=1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3
InChIKey: KVWDHTXUZHCGIO-UHFFFAOYSA-N
SMILES: N1C2=CC=CC=C2N=C(N2CCN(C)CC2)C2C=C(C)SC1=2
CAS Datenbank: 132539 · 132539-06-1(CAS DataBase Reference)
NIST chemische Informationen: Olanzapine(132539-06-1)

Sicherheit und Regulatorisches

Sicherheitsdaten

wgk: 3
ridadr: UN 2811 6.1 / PGIII
hs_code: 29349990
RTECS-Nr.: XJ9007750
risk_code: 36/38-36-20/21/22-11
Toxizität: human,TDLo,oral,16560ug/kg/12 (16.56mg/kg),Journal of Clinical Psychiatry. Vol. 60, Pg. 767, 1999.
hazard_code: Xi,Xn,F
safety_code: 26-36/37-16
hazard_class: 6.1
packing_group: III
Speicherklasse: 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Giftige Stoffe Daten: 132539-06-1(Hazardous Substances Data)
Hazard Classifications: Acute Tox. 3 OralSkin Irrit. 2Skin Sens. 1STOT SE 3

Chemie und Industrie

Anwendungen · 2 Einträge

BeschreibungZyprexa was launched in Canada, Germany, the UK and US as an antipsychotic agent. Prepared in three steps via the intermediate diazepinone, it is an atypical antipsychotic with a high affinity for dopaminergic and serotonergic receptors. Specifically, olazapine is a potent 5-HT2/D2 antagonist with anticholinergic activity. It has a greater antagonistic effect at 5-HT2a than at dopamine D2 receptors and in vivo is clozapine-like. Thus it is less likely to produce extrapyramidal side effects and does not produce any granulocytopenia. Its 10 metabolic products are all inactive.

VerwendenA serotonin (5-HT2) and dopamine (D1/D2) receptor antagonist with anticholinergic activity. Antipsychotic.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

Aza Dimethylsulfoxid Zinnchlorid Propionaldehyd 2-Fluoronitrobenzene 1-Methylpiperazin 10H-Thieno[2,3-b][1,5]benzodiazepine, 2-methyl-4-(4-methyl-1-piperazinyl)-10-(phenylmethyl)-Dimethylsulfat N-Demethyl olanzapine 2-Methyl-10H-thieno[2,3-b][1,5]benzodiazepin-4-aMine

Anbieter100 Anbieter

国药集团化学试剂有限公司86-21-63210123 · [email protected]

北京华美互利生物化工010-56205725 · [email protected]

梯希爱(上海)化成工业发展有限公司021-67121386 · [email protected]

上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]

INTATRADE GmbH+49 3493/605464 · [email protected]

Ergänzende Hinweise

DefinitionChEBI: A benzodiazepine that is 10H-thieno[2,3-b][1,5]benzodiazepine substituted by a methyl group at position 2 and a 4-methylpiperazin-1-yl group at position 4.